Eko Health

Company profile

About Eko Health

Eko Health has reimagined the traditional stethoscope for modern medicine by combining digital audio technology with FDA-cleared artificial intelligence. The company's flagship products include the CORE 500 Digital Stethoscope and the 3M Littmann CORE Digital Stethoscope, which feature enhanced audio with active noise cancellation, visual waveforms, 3-lead ECG capabilities, and AI algorithms that detect cardiac conditions including murmurs, atrial fibrillation, and low ejection fraction. Eko's SENSORA Platform enables health systems to deploy AI-powered cardiac screening across their entire organization, supporting both in-person and telehealth encounters. The technology has been clinically validated in over 70 publications and has received 9 FDA clearances. Research shows that providers using Eko are twice as likely to detect heart disease compared to traditional methods. With more than 750,000 devices sold, Eko serves individual healthcare providers, health systems, life science companies conducting clinical trials, and veterinary medicine. The company's mission is to transform every patient encounter into an opportunity for earlier disease detection, addressing the critical problem that over 60% of heart diseases go undiagnosed. Eko's solutions integrate with existing healthcare workflows and telehealth platforms, enabling automatic record keeping, longitudinal patient monitoring, and the ability to share recordings for second opinions.

Company description · Eko Health official website